Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000420333 | SCV000333995 | pathogenic | not provided | 2017-01-30 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000382987 | SCV000486122 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2016-11-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000420333 | SCV000517213 | pathogenic | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 15689361, 32528171, 10330340, 26404900, 18055493) |
Fulgent Genetics, |
RCV000763350 | SCV000894040 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A; Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000382987 | SCV001218172 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-10-17 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 17 of the CAPN3 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CAPN3 are known to be pathogenic (PMID: 10330340, 15689361). This variant is present in population databases (rs369552114, gnomAD 0.003%). Disruption of this splice site has been observed in individuals with clinical features of autosomal recessive limb-girdle muscular dystrophy (PMID: 18055493; Invitae). ClinVar contains an entry for this variant (Variation ID: 282494). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000420333 | SCV002018068 | pathogenic | not provided | 2020-02-21 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000382987 | SCV002085544 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2021-07-15 | no assertion criteria provided | clinical testing | |
Baylor Genetics | RCV003475894 | SCV004211564 | pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2023-09-13 | flagged submission | clinical testing |